CSPC Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
CSPC Pharmaceutical Group has a total shareholder equity of CN¥35.0B and total debt of CN¥706.9M, which brings its debt-to-equity ratio to 2%. Its total assets and total liabilities are CN¥46.3B and CN¥11.3B respectively. CSPC Pharmaceutical Group's EBIT is CN¥7.3B making its interest coverage ratio -31.4. It has cash and short-term investments of CN¥13.8B.
Key information
2.0%
Debt to equity ratio
CN¥706.90m
Debt
Interest coverage ratio | -31.4x |
Cash | CN¥13.76b |
Equity | CN¥35.02b |
Total liabilities | CN¥11.26b |
Total assets | CN¥46.28b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1093's short term assets (CN¥26.7B) exceed its short term liabilities (CN¥10.2B).
Long Term Liabilities: 1093's short term assets (CN¥26.7B) exceed its long term liabilities (CN¥1.1B).
Debt to Equity History and Analysis
Debt Level: 1093 has more cash than its total debt.
Reducing Debt: 1093's debt to equity ratio has increased from 0.6% to 2% over the past 5 years.
Debt Coverage: 1093's debt is well covered by operating cash flow (591.1%).
Interest Coverage: 1093 earns more interest than it pays, so coverage of interest payments is not a concern.